GILL DAVID N 4
4 · Evolus, Inc. · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Evolus (EOLS) Director David N. Gill Receives RSU Award
What Happened
David N. Gill, a director of Evolus, was granted 45,559 restricted stock units (RSUs) on February 17, 2026. The Form 4 shows an acquisition type "A" at $0.00 per share (total reported value $0) because RSUs are contingent awards rather than cash purchases. These RSUs convert to one share each upon vesting.
Key Details
- Transaction date: 2026-02-17; Form 4 filed: 2026-02-19 (timely filing).
- Grant: 45,559 RSUs; reported price per share: $0.00; reported cash value at grant: $0.
- Shares owned after transaction: not specified in the provided filing.
- Footnote: RSUs vest in full on the one-year anniversary of Feb 17, 2026 (i.e., Feb 17, 2027) provided continuous service; vesting may accelerate in certain events (including certain change-of-control scenarios).
- Transaction code: A = Award/Acquisition of stock-based compensation.
Context
RSUs are a form of equity compensation that give the recipient a contingent right to receive shares in the future (typically taxed when they vest). Because no shares were purchased or sold on the open market and no cash changed hands at grant, this transaction reflects compensation rather than a market vote by the insider. Vesting and any accelerated vesting terms determine when shares will be delivered.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-17+45,559→ 86,887 total
Footnotes (1)
- [F1]Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 17, 2026, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.